Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 5
1997 9
1998 5
1999 6
2000 7
2001 6
2002 14
2003 11
2004 12
2005 5
2006 8
2007 10
2008 5
2009 9
2010 3
2011 11
2012 2
2013 1
2014 4
2015 5
2016 1
2018 1
2019 3
2020 3
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.
Schäkel K, Reich K, Asadullah K, Pinter A, Jullien D, Weisenseel P, Paul C, Gomez M, Wegner S, Personke Y, Kreimendahl F, Chen Y, Angsana J, Leung MWL, Eyerich K. Schäkel K, et al. Among authors: asadullah k. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):2016-2027. doi: 10.1111/jdv.19236. Epub 2023 Jul 18. J Eur Acad Dermatol Venereol. 2023. PMID: 37262309 Clinical Trial.
Mechanisms involved in the side effects of glucocorticoids.
Schäcke H, Döcke WD, Asadullah K. Schäcke H, et al. Among authors: asadullah k. Pharmacol Ther. 2002 Oct;96(1):23-43. doi: 10.1016/s0163-7258(02)00297-8. Pharmacol Ther. 2002. PMID: 12441176 Review.
Immunotherapy in psoriasis.
Landeck L, Sabat R, Ghoreschi K, Man XY, Fuhrmeister K, Gonzalez-Martinez E, Asadullah K. Landeck L, et al. Among authors: asadullah k. Immunotherapy. 2021 May;13(7):605-619. doi: 10.2217/imt-2020-0292. Epub 2021 Apr 6. Immunotherapy. 2021. PMID: 33820446 Review.
Zytokine der IL-17-Familie bei der Psoriasis.
Lauffer F, Eyerich K, Boehncke WH, Asadullah K, Beissert S, Ghoreschi K, Schön MP. Lauffer F, et al. Among authors: asadullah k. J Dtsch Dermatol Ges. 2020 Jul;18(7):675-681. doi: 10.1111/ddg.14124_g. J Dtsch Dermatol Ges. 2020. PMID: 32713148 Review. German.
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE).
Eyerich K, Weisenseel P, Pinter A, Schäkel K, Asadullah K, Wegner S, Muñoz-Elias EJ, Bartz H, Taut FJH, Reich K. Eyerich K, et al. Among authors: asadullah k. BMJ Open. 2021 Sep 13;11(9):e049822. doi: 10.1136/bmjopen-2021-049822. BMJ Open. 2021. PMID: 34518264 Free PMC article.
Immunopathogenesis of psoriasis.
Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K, Volk HD, Sterry W, Wolk K. Sabat R, et al. Among authors: asadullah k. Exp Dermatol. 2007 Oct;16(10):779-98. doi: 10.1111/j.1600-0625.2007.00629.x. Exp Dermatol. 2007. PMID: 17845210 Review.
Cytokines of the IL-17 family in psoriasis.
Lauffer F, Eyerich K, Boehncke WH, Asadullah K, Beissert S, Ghoreschi K, Schön MP. Lauffer F, et al. Among authors: asadullah k. J Dtsch Dermatol Ges. 2020 Jul;18(7):675-681. doi: 10.1111/ddg.14124. Epub 2020 May 24. J Dtsch Dermatol Ges. 2020. PMID: 32447845 Review.
Novel immunotherapies for psoriasis.
Asadullah K, Volk HD, Sterry W. Asadullah K, et al. Trends Immunol. 2002 Jan;23(1):47-53. doi: 10.1016/s1471-4906(01)02119-6. Trends Immunol. 2002. PMID: 11801454 Review.
Glucocorticoid therapy-induced skin atrophy.
Schoepe S, Schäcke H, May E, Asadullah K. Schoepe S, et al. Among authors: asadullah k. Exp Dermatol. 2006 Jun;15(6):406-20. doi: 10.1111/j.0906-6705.2006.00435.x. Exp Dermatol. 2006. PMID: 16689857 Review.
What makes a good drug target?
Gashaw I, Ellinghaus P, Sommer A, Asadullah K. Gashaw I, et al. Among authors: asadullah k. Drug Discov Today. 2011 Dec;16(23-24):1037-43. doi: 10.1016/j.drudis.2011.09.007. Epub 2011 Sep 16. Drug Discov Today. 2011. PMID: 21945861 Review.
146 results